首页 > 组织芯片 > > DLV8011
tissue microarray-DLV8011
  • 点数:
    80
    例数:
    80
    点样直径(mm):
    2
    厚度(µm):
    5
    行数:
    8
    列数:
    10
    组织阵列类型:
    FFPE
    种属:
    Human
DLV8011
加入收藏

描述: 肝脏疾病谱(肝癌演变史)组织芯片,附病理分级、TNM和临床分期,80例/80点

详情: 肝脏疾病谱(肝癌演变史)组织微阵列,包含肝细胞肝癌30例,胆管细胞癌17例,肝硬化17例,肝炎6例,边缘肝组织和肝组织各5例,一例一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • 说明书列表
  • 重复病例
  • 下载说明书
图表:
Liver
  • Cirrhosis(*)
  • Inflammation(*)
  • Malignant(*)
  • Malignant(IB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(IVA)
  • NAT(*)
  • Normal(*)
  • _ma
组织芯片
DLV8011
1
2
3
4
5
6
7
8
9
10
A
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
B
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
C
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
D
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
E
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
F
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
G
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
H
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
_ma
DLV8011
  • 年龄:
  • 性别:
  • 器官/解剖部位:
  • 病理诊断:
  • 等级:
  • 分期:
  • 阶段:
  • 组织ID.:
  • 类型:
POS No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 63 M Liver Hepatocellular carcinoma 1 T3N0M0 IIIA Malignant *
A2
2 65 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant *
A3
3 62 F Liver Hepatocellular carcinoma 1--2 T3N0M0 IIIA Malignant *
A4
4 40 M Liver Hepatocellular carcinoma with necrosis 2 T3N1M0 IVA Malignant *
A5
5 40 M Liver Hepatocellular carcinoma with necrosis 2 * * Malignant *
A6
6 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 7*7*6
A7
7 72 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*5.0*3.5
A8
8 58 F Liver Hepatocellular carcinoma 2 T1bN0M0 IB Malignant 7.0*6.0*4.5
A9
9 36 F Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
A10
10 57 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.5*5.0*3.5
B1
11 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B2
12 48 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B3
13 62 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B4
14 51 M Liver Hepatocellular carcinoma with necrosis 2 T3N0M0 IIIA Malignant *
B5
15 63 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant *
B6
16 40 M Liver Hepatocellular carcinoma with necrosis 2 T3N0M0 IIIA Malignant *
B7
17 54 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B8
18 49 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B9
19 60 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant *
B10
20 47 M Liver Hepatocellular carcinoma 2--3 T3N0M0 IIIA Malignant 8.5*6.0*3.5
C1
21 27 F Liver Hepatocellular carcinoma 3 T4N0M0 IIIB Malignant *
C2
22 32 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant *
C3
23 57 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant *
C4
24 51 F Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant *
C5
25 60 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 8.0*7*5
C6
26 66 M Liver Hepatocellular carcinoma 2 T2N1M0 IVA Malignant 5
C7
27 69 M Liver Hepatocellular carcinoma 3 T3N1M0 IVA Malignant 7
C8
28 51 M Liver Hepatocellular carcinoma with necrosis 3 T3aN1M0 IVA Malignant 6
C9
29 77 F Liver Hepatocellular carcinoma with necrosis 3 T3N0M0 IIIA Malignant 7
C10
30 63 M Liver Hepatocellular carcinoma 2--3 T2N0M0 II Malignant 4.0*3.5*2.5
D1
31 67 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant *
D2
32 58 F Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant *
D3
33 69 M Liver Cholangiocellular carcinoma 2 T2aN0M0 II Malignant *
D4
34 56 F Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant *
D5
35 47 M Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant *
D6
36 62 M Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant *
D7
37 49 M Liver Cholangiocellular carcinoma with necrosis 2 T2aN0M0 II Malignant *
D8
38 54 M Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant 3.5*3.0*2.0
D9
39 68 F Liver Cholangiocellular carcinoma 2 T2N0M0 II Malignant 4.0*3.5*3.0
D10
40 58 F Liver Cholangiocellular carcinoma with necrosis 2 T2N0M0 II Malignant *
E1
41 50 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant *
E2
42 50 F Liver Cholangiocellular carcinoma 2 T3N1M0 IIIB Malignant *
E3
43 62 M Liver Cholangiocellular carcinoma 2--3 T2aN0M0 II Malignant 6
E4
44 60 F Liver Cholangiocellular carcinoma 2 T3N0M0 IIIA Malignant 7
E5
45 64 M Liver Cholangiocellular carcinoma with necrosis 3 T3N1M0 IIIB Malignant *
E6
46 57 M Liver Cholangiocellular carcinoma 3 T3N0M0 IIIA Malignant 9
E7
47 65 M Liver Cholangiocellular carcinoma 3 T3N0M0 IIIA Malignant 7
E8
48 37 M Liver Cirrhosis * * * Cirrhosis *
E9
49 55 M Liver Cirrhosis * * * Cirrhosis *
E10
50 46 M Liver Cirrhosis * * * Cirrhosis *
F1
51 65 M Liver Cirrhosis * * * Cirrhosis *
F2
52 37 M Liver Cirrhosis * * * Cirrhosis *
F3
53 24 M Liver Cirrhosis * * * Cirrhosis *
F4
54 53 F Liver Cirrhosis * * * Cirrhosis *
F5
55 62 M Liver Cirrhosis * * * Cirrhosis *
F6
56 36 M Liver Cirrhosis * * * Cirrhosis *
F7
57 58 M Liver Cirrhosis (moderate inflammation) * * * Cirrhosis *
F8
58 69 M Liver Cirrhosis * * * Cirrhosis *
F9
59 52 F Liver Cirrhosis * * * Cirrhosis *
F10
60 45 M Liver Cirrhosis * * * Cirrhosis *
G1
61 34 M Liver Cirrhosis * * * Cirrhosis *
G2
62 53 M Liver Cirrhosis * * * Cirrhosis *
G3
63 62 M Liver Cirrhosis * * * Cirrhosis *
G4
64 56 M Liver Cirrhosis * * * Cirrhosis *
G5
65 42 M Liver Moderate-severe inflammation * * * Inflammation *
G6
66 69 M Liver Mild inflammation * * * Inflammation *
G7
67 64 M Liver Mild inflammation * * * Inflammation *
G8
68 56 M Liver Mild inflammation * * * Inflammation *
G9
69 46 M Liver Mild inflammation * * * Inflammation *
G10
70 51 M Liver Mild-moderate inflammation * * * Inflammation *
H1
71 46 M Liver Adjacent normal liver tissue (mild inflammation) * * * NAT *
H2
72 45 M Liver Adjacent normal liver tissue (mild inflammation) * * * NAT *
H3
73 63 M Liver Adjacent normal liver tissue (mild inflammation) * * * NAT *
H4
74 47 M Liver Adjacent normal liver tissue (mild inflammation) * * * NAT *
H5
75 45 M Liver Adjacent normal liver tissue (mild inflammation) * * * NAT *
H6
76 23 M Liver Liver tissue (mild inflammation) * * * Normal *
H7
77 45 M Liver Liver tissue (mild inflammation) * * * Normal *
H8
78 43 M Liver Liver tissue (mild inflammation) * * * Normal *
H9
79 6 Mon. F Liver Liver tissue (mild-moderate inflammation) * * * Normal *
H10
80 38 M Liver Liver tissue (mild inflammation) * * * Normal *
_marker_
查找与该芯片存在重复病例的芯片:
如需了解产品规格方面的任何问题,请联系我们
0.082984s